Page last updated: 2024-09-05

sorafenib and rtki cpd

sorafenib has been researched along with rtki cpd in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(rtki cpd)
Trials
(rtki cpd)
Recent Studies (post-2010) (rtki cpd)
6,5207305,25141021

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)rtki cpd (IC50)
Tyrosine-protein kinase ABL1Homo sapiens (human)0.125
Epidermal growth factor receptorHomo sapiens (human)0.1152
Fructose-1,6-bisphosphatase 1Homo sapiens (human)1.3
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)2.7
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.56
Tyrosine-protein kinase ABL2Homo sapiens (human)0.125
Epidermal growth factor receptorMus musculus (house mouse)0.1
Mitogen-activated protein kinase 14Homo sapiens (human)0.56
MAP kinase-interacting serine/threonine-protein kinase 1Homo sapiens (human)0.53
Histamine H3 receptorRattus norvegicus (Norway rat)1.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Caballero, E; García-Cárceles, J; Gil, C; Martínez, A1

Reviews

1 review(s) available for sorafenib and rtki cpd

ArticleYear
Kinase Inhibitors as Underexplored Antiviral Agents.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Animals; Antiviral Agents; Drug Repositioning; Humans; Protein Kinase Inhibitors; Virus Diseases; Viruses

2022